DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Clozaril (Clozapine) - Published Studies

 
 



Clozaril Related Published Studies

Well-designed clinical trials related to Clozaril (Clozapine)

Choice of randomization to clozapine versus other second generation antipsychotics in the CATIE schizophrenia trial. [2012]

Effects of sertindole on cognition in clozapine-treated schizophrenia patients. [2012]

Augmentation of clozapine with a second antipsychotic - a meta-analysis. [2012]

Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review. [2012]

Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia: a randomized, placebo-controlled trial. [2011.11]

Effects of modafinil on weight, glucose and lipid metabolism in clozapine-treated patients with schizophrenia. [2011.08]

A pilot double-blind sham-controlled trial of repetitive transcranial magnetic stimulation for patients with refractory schizophrenia treated with clozapine. [2011.07.30]

Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial. [2011.06]

Treatment effects of traditional Chinese medicines Suoquan Pill and Wuling Powder on clozapine-induced hypersalivation in patients with schizophrenia: study protocol of a randomized, placebo-controlled trial. [2011.05]

Current treatment strategies for clozapine-induced sialorrhea. [2011.05]

Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapy. [2011.05]

Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study. [2011.05]

Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine. [2011.04]

Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study. [2011.04]

Pharmacological Augmentation Strategies for Schizophrenia Patients With Insufficient Response to Clozapine: A Quantitative Literature Review. [2011.03.21]

Orlistat in clozapine- or olanzapine-treated patients with overweight or obesity: a 16-week open-label extension phase and both phases of a randomized controlled trial. [2011.03]

Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia: a randomized, placebo-controlled trial. [2011]

Treatment effects of traditional Chinese medicines Suoquan Pill and Wuling Powder on clozapine-induced hypersalivation in patients with schizophrenia: study protocol of a randomized, placebo-controlled trial. [2011]

Clozapine v. chlorpromazine in treatment-naive, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial. [2011]

Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine. [2010.10]

Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial. [2010.09]

Orlistat in clozapine- or olanzapine-treated patients with overweight or obesity: a 16-week open-label extension phase and both phases of a randomized controlled trial. [2010.08.24]

Polymorphisms of the LEP- and LEPR genes, metabolic profile after prolonged clozapine administration and response to the antidiabetic metformin. [2010.08]

Long-term efficacy and tolerability of clozapine combined with ziprasidone or risperidone. [2010.08]

Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study. [2010.07.08]

Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study. [2010.06]

A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia. [2010.05.30]

Does therapeutic equivalence follow bioequivalence? A randomized trial to assess clinical effects after switching from Clozaril to generic clozapine (gen-clozapine). [2010.05]

[Observation on the therapeutic effect of electroacupuncture combined with small dose of clozapine in clinical treatment of refractory schizophrenia] [2010.04]

Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study. [2010]

Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial. [2009.12]

Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine. [2009.10]

Treatment of clozapine-induced hypersalivation with ipratropium bromide: a randomized, double-blind, placebo-controlled crossover study. [2009.08]

Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study. [2009.08]

Extended release metformin for metabolic control assistance during prolonged clozapine administration: a 14 week, double-blind, parallel group, placebo-controlled study. [2009.08]

The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variation. [2009.06]

A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophrenia. [2009.06]

Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia. [2009.05.15]

Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study. [2009.05]

Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol. [2009.05]

Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial. [2009.05]

The efficacy of lamotrigine in clozapine-resistant schizophrenia: a systematic review and meta-analysis. [2009.04]

Higher serum clozapine level is associated with increased antiphospholipid antibodies in schizophrenia patients. [2009.03]

The efficacy of lamotrigine in clozapine-resistant schizophrenia: A systematic review and meta-analysis. [2009.01.29]

A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with Schizophrenia. [2009.01.09]

Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever. [2009.01]

Effect of food on the pharmacokinetics of clozapine orally disintegrating tablet 12.5 mg: a randomized, open-label, crossover study in healthy male subjects. [2009]

A randomized double-blind comparison of ziprasidone vs. clozapine for cognition in patients with schizophrenia selected for resistance or intolerance to previous treatment. [2008.10]

Clozapine versus "high-dose" olanzapine in refractory early-onset schizophrenia: an open-label extension study. [2008.08]

A placebo-controlled study of extract of ginkgo biloba added to clozapine in patients with treatment-resistant schizophrenia. [2008.07]

A randomized controlled trial of the cost-utility of second-generation antipsychotics in people with psychosis and eligible for clozapine. [2008.07]

Orlistat in clozapine- or olanzapine-treated patients with overweight or obesity: a 16-week randomized, double-blind, placebo-controlled trial. [2008.05]

Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial. [2008.05]

Aripiprazole Augmentation in Clozapine-Treated Patients With Refractory Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial. [2008.03.18]

Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity: A 16-Week Randomized, Double-Blind, Placebo-Controlled Trial. [2008.03.11]

Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison. [2008.03.01]

A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia. [2008.02]

Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial. [2008.01]

A Randomized Controlled Trial of the Cost-Utility of Second-Generation Antipsychotics in People with Psychosis and Eligible for Clozapine. [2007.12.18]

Effects of repetitive transcranial magnetic stimulation on auditory hallucinations refractory to clozapine. [2007.10]

Clozapine treatment of childhood-onset schizophrenia: evaluation of effectiveness, adverse effects, and long-term outcome. [2007.10]

The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: a double-blind, placebo-controlled study. [2007.07]

Augmentation with a second antipsychotic in patients with schizophrenia who partially respond to clozapine: a meta-analysis. [2007.04]

The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: A double-blind, placebo-controlled study. [2007.03.23]

A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain. [2007.02]

Comparison of clozapine-amisulpride and clozapine-quetiapine combinations for patients with schizophrenia who are partially responsive to clozapine: a single-blind randomized study. [2007.01]

A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition. [2006.12]

Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis. [2006.11]

Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. [2006.10]

Clozapine enhances prepulse inhibition in healthy humans with low but not with high prepulse inhibition levels. [2006.09.15]

Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia. [2006.09.15]

Risperidone augmentation of clozapine : A critical review. [2006.09]

Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison. [2006.07]

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. [2006.05]

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. [2006.04]

Effects of clozapine plus lamotrigine on phencyclidine-induced hyperactivity. [2006.03]

Clozapine alone versus clozapine and risperidone with refractory schizophrenia. [2006.02.02]

An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia. [2006.02]

Effects of clozapine plus lamotrigine on phencyclidine-induced hyperactivity. [2005.11.19]

Influence of atypical neuroleptics on executive functioning in patients with schizophrenia: a randomized, double-blind comparison of olanzapine vs. clozapine. [2005.09.21]

Randomized controlled augmentation trials in clozapine-resistant schizophrenic patients: a critical review. [2005.08]

Does clozapine decrease smoking? [2005.06]

The effects of clozapine and risperidone on spatial working memory in schizophrenia. [2005.05]

Steady-state bioequivalence study of clozapine tablet in schizophrenic patients. [2005.02.25]

Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia. [2005.02]

Plasma clozapine concentration coefficients of variation in a long-term study. [2005.01.01]

A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety. [2005.01]

Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial. [2005.01]

Possible individual and gender differences in the small increases in plasma prolactin levels seen during clozapine treatment. [2004.10]

Cerebral D2 and 5-HT2 receptor occupancy in Schizophrenic patients treated with olanzapine or clozapine. [2004.09]

Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis. [2004.07]

Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross-over study. [2004.07]

The differential effects of steady-state fluvoxamine on the pharmacokinetics of olanzapine and clozapine in healthy volunteers. [2004.07]

Adjunctive fluvoxamine inhibits clozapine-related weight gain and metabolic disturbances. [2004.06]

Patterns of concomitant psychotropic medication use during a 2-year study comparing clozapine and olanzapine for the prevention of suicidal behavior. [2004.05]

Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up. [2004.05]

Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol. [2004.04]

The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled study. [2004.03]

Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study. [2004.02.10]

Do clozapine and risperidone affect social competence and problem solving? [2004.02]

Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol. [2004.01]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012